GlassScriptPhysician profile
Olga Liberman
NPI 1518982610
$845.85
in general payments reported to CMS, 2019-2025
18 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.48 · 2020: $19.55 · 2022: $96.10 · 2023: $65.62 · 2024: $193 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630 · Gift: $25.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.39 |
| Gift | $25.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $166.75 | 2019-2024 | Myrbetriq, Veozah |
| Exact Sciences Corporation | $99.15 | 2024-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $80.61 | 2024-2025 | Vyepti |
| Janssen Biotech, INC. | $73.96 | 2025 | Tremfya |
| Lilly USA, LLC | $67.49 | 2024-2025 | Omvoh |
| Caldera Medical, INC | $55.92 | 2022-2023 | Desara |
| Medtronic, INC. | $36.08 | 2025 | Interstim |
| Axonics, INC. | $33.97 | 2023-2024 | Bulkamid |
| Hologic Sales and Service, LLC | $33.14 | 2025 | Fluent Fluid Management System |
| Grifols USA, LLC | $31.82 | 2025 | Gamunex-C |
| Takeda Pharmaceuticals U.S.A., INC. | $26.05 | 2025 | Entyvio |
| Daiichi Sankyo INC. | $23.12 | 2024 | Injectafer |
| Coloplast Corp | $22.21 | 2025 | |
| Neurocrine Biosciences, INC. | $22.11 | 2024 | Ingrezza |
| Ucb, INC. | $21.83 | 2025 | Rystiggo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $19.90 | 2019 | |
| Abbvie INC. | $16.46 | 2024 | |
| Tersera Therapeutics LLC | $15.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Liberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.